Advertisement
In a letter to states and union territories, the Centre said necessary provisions have been made on the Co-WIN portal to enable updating of the precaution dose so administered and citizens will not be required to upload documents such as visas.
The Health Ministry received several requests for the early administration of precaution dose to those who need to undertake international travel for educational purposes, employment opportunities, participation in sports tournaments, attending bilateral and multilateral meetings as part of India’s official delegation, and business commitments, Additional Secretary in the ministry Manohar Agnani said.
In this context, to facilitate international travel for such genuine reasons, the necessary provision of early administration of precaution dose for these travelers has been done on the Co-WIN portal under the National COVID-19 Vaccination Programme, Agnani said in the guidelines shared by him.
Related Articles
Advertisement
”The necessary provisions for the same have been made on Co-WIN,” Agnani stated.
”It is requested that the guidelines may be widely publicized to all government and private CVCs and for the general public and all necessary measures be taken immediately for the implementation of the same,” he said.
Currently, healthcare workers, frontline workers, and citizens aged 60 years and above who are fully vaccinated (with two doses) and have completed nine months (39 weeks) after the second dose are eligible to take the precaution dose at any of the government or private COVID-19 Vaccination Centres (CVCs).
Citizens aged 18 years and more but less than 60 years are allowed to take the precaution dose only at private CVCs on a payment basis. It can be also availed at government CVCs in a few states, based on the respective state’s notification, the letter mentioned.
The vaccine administered as a precaution dose is a homologous vaccine that is the same as what has been administered in the first and second doses.
All technical protocols as prescribed in the guidelines regarding vaccination centers and adverse events following immunization (AEFI) management will have to be followed, the guidelines added.